Bioequivalence Study Between a 4-mg Dose of Fine Granules of Perampanel and a 4-mg Tablet of Perampanel in Healthy Japanese Subjects
Clinical trial NCT03399734 · COMPLETED
Trial details
- NCT number
- NCT03399734
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-18
- Primary completion
- 2018-03-09
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.